• 1
    Hart, F. D., and Boardman, P. L.: Indomethacin: a new non-steroid anti-inflammatory agent. Brit. Med. J. 2:965, 1963.
  • 2
    Katz, A. M., Pearson, C. M., and Kennedy, J. J.: The antirheumatic effects of indomethacin in rheumatoid arthritis and other rheumatic diseases. Arthritis Rheum. 6:281, 1963.
  • 3
    Norcross, B. M.: Treatment of connective tissue diseases with a new non-steroid compound (indomethacin). Arthritis Rheum. 6:290, 1963.
  • 4
    Winter, C. A., Risley, E. A., and Nuss, C. W.: Anti-inflammatory and antipyretic activities of indomethacin, 1-(p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid. J. Pharmacol. Exp. Ther. 141:369, 1963.
  • 5
    Silberman, H. R., McGinn, T. G., and Kremer, W. B.: Control of fever in Hodgkin's disease by indomethacin. J. A. M. A. 194(6):597, 1965.
  • 6
    Vignau, A. I., Correa, E. T., Guasch, J. L., Schuster, A. C., Patri, A. M., Vaisman, S. B., and Mortimer, E. A.: The effects of indomethacin on rheumatic fever. Arthritis Rheum. 8(4):501, 1965.
  • 7
    Colgan, M. T., and Mintz, A. A.: The comparative antipyretic effect of N-acetyl-p-aminophenol and acetylsalicylic acid. J. Pediat. 50(5):552, 1957.
  • 8
    Winter, C. A.: Anti-inflammatory testing methods: comparative evaluation of indomethacin and other agents. Excerpta Med. Intern. Conf. Series, No. 82:190, 1965.
  • 9
    Hucker, H. B., Zacchei, A. G., Cox, S. V., Brodie, D. A., and Cantwell, N. H. R.: Studies on the absorption, distribution, and excretion of indomethacin in various species. J. Pharmacol. Exp. Ther. 153(2):237, 1966.
  • 10
    Merck, Sharp & Dohme Research Laboratories: Informational material on indocin (indomethacin), p. S-7, 1964.
  • 11
    Lockie, L. M. and Norcross, B. M.: Salicylates, phenylbutazone, chloroquines, and indomethacin in treatment of rheumatoid arthritis. In: Hollander, J. L., Arthritis and Allied Conditions, Philadelphia, Lea & Febiger, 1966.
  • 12
    Wanka, J., Jones, L., Wood, P. H., Dixon, A. St. J.: Indomethacin in rheumatic diseases. A controlled clinical trial. Ann. Rheum. Dis. 23:218, 1964.
  • 13
    Vanselou, N. A.: Bronchial asthma induced by indomethacin. Ann. Intern. Med. 66(3):568, 1967.
  • 14
    Chapman, R. A.: Suspected adverse reactions to indomethacin. Canad. Med. Ass. J. 95:1156, 1966.
  • 15
    Jacobs, J. C.: Sudden death in arthritic children receiving large doses of indomethacin. J. A. M. A. 199(12):932, 1967.
  • 16
    Kelsey, W. M., and Sharyj, M.: Fatal hepatitis probably due to indomethacin. J. A. M. A. 199(8):586, 1967.